scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1464-5491.1984.TB01915.X |
P698 | PubMed publication ID | 6242771 |
P2093 | author name string | G C Viberti | |
R J Jarrett | |||
T J Murrells | |||
R D Hill | |||
A Argyropoulos | |||
U Mahmud | |||
P433 | issue | 1 | |
P304 | page(s) | 17-19 | |
P577 | publication date | 1984-05-01 | |
P1433 | published in | Diabetic Medicine | Q15758639 |
P1476 | title | Microalbuminuria predicts mortality in non-insulin-dependent diabetics | |
P478 | volume | 1 |
Q39236326 | 'Microalbuminuria' and diabetes: a critique--assessment of urinary albumin excretion and its role in screening for diabetic nephropathy |
Q44940887 | 'Microalbuminuria' in type I (insulin-dependent) diabetic patients with and without retinopathy |
Q72249253 | A charge selectivity impairment in protein permselectivity is present in type 2 diabetes |
Q41332341 | ACE inhibitors and proteinuria |
Q68365130 | Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion |
Q71564790 | Albumin excretion and vascular deaths in NIDDM |
Q51025301 | Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy. |
Q67901191 | Albuminuria and associated medical risk factors: A cross-sectional study in 451 type II (noninsulin-dependent) diabetic patients. Part 2 |
Q43628515 | Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians |
Q38672988 | Albuminuria reflects widespread vascular damage. The Steno hypothesis. |
Q37412684 | Albuminuria: what can we expect from the determination of nonimmunoreactive albumin? |
Q35642519 | Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications |
Q24803174 | An interaction between the interleukin-6 -174G>C gene variant and urinary protein excretion influences plasma oxidative stress in subjects with type 2 diabetes |
Q35766610 | Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy. The Melbourne Diabetic Nephropathy Study Group |
Q40754772 | Antiplatelet agents in the prevention of diabetic vascular complications. |
Q37096470 | Are Conventional Risk Factors for Mortality Relevant in Type 2 Diabetes? |
Q70989583 | Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics |
Q71293195 | Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM |
Q44235869 | Blood Rheology and Cardiovascular Risk Factors in Type 1 Diabetes: Relationship with Microalbuminuria |
Q77579335 | Calcium antagonists and cardiovascular risk in diabetes |
Q43859914 | Cardio vascular morbidity in proteinuric south Indian NIDDM patients |
Q33843624 | Cardiovascular disease in diabetic patients |
Q62113326 | Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects |
Q39748118 | Clinical diabetic nephropathy: natural history and complications |
Q67822063 | Clinical significance of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes |
Q36597794 | Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. |
Q44157415 | Comparison of early renal dysfunction in type I and type II diabetes: differing associations with blood pressure and glycaemic control |
Q68325939 | Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients |
Q69022404 | Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors |
Q35627938 | Cost-effective strategies in the prevention of diabetic nephropathy |
Q34053578 | Danish general practitioners' estimation of urinary albumin concentration in the detection of proteinuria and microalbuminuria. |
Q59150879 | Determinants of end-stage renal disease in Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus and proteinuria |
Q37079790 | Diabetes and Arterial Disease |
Q41563034 | Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention |
Q33883966 | Diabetic nephropathy. Prevention and early referral |
Q41094725 | Diabetic vascular injury and ACE. Potential for pharmacological prevention of complications of later life |
Q33815573 | Dose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure |
Q35576079 | Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease |
Q72877433 | Early recognition of autonomic dysfunction in microalbuminuria: significance for cardiovascular mortality in diabetes mellitus? |
Q36456306 | Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). |
Q69311611 | Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats |
Q68028511 | Eight to nine year mortality in known non-insulin dependent diabetics and controls |
Q73936725 | Elevated urinary albumin excretion is not linked to the angiotensin I-converting enzyme gene polymorphism in clinically healthy subjects |
Q44178748 | Epidemiologic study of type 2 diabetes in Taiwan |
Q41388533 | Epidemiology of non-insulin-dependent diabetes mellitus and its macrovascular complications. A basis for the development of cost-effective programs |
Q36756205 | Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark |
Q42494570 | Features of endothelial dysfunction in early diabetic nephropathy |
Q33400488 | Glomerular endothelium: a porous sieve and formidable barrier. |
Q40781789 | Glomerulosclerosis in type 2 (non-insulin-dependent) diabetes mellitus: relationship to glycaemia in the University Group Diabetes Program (UGDP). |
Q70266880 | Hypertension |
Q41263538 | Hypertension in diabetes mellitus. |
Q27004016 | Impact of microalbuminuria on incident coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis of prospective studies |
Q36896206 | Impaired aerobic work capacity in insulin dependent diabetics with increased urinary albumin excretion |
Q43709282 | Impaired autoregulation of the retinal vasculature and microalbuminuria in diabetes mellitus |
Q83104034 | Impaired fibrinolytic activity in type II diabetes: correlation with urinary albumin excretion and progression of renal disease |
Q36264790 | Incidence of microalbuminuria in tobacco chewers |
Q74100672 | Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men |
Q74578663 | Initial urinary albumin excretion determines the progression of microalbuminuria in patients with type-2 diabetes and normotensive blood pressure values despite improved metabolic control |
Q51590370 | Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. |
Q50936894 | Insulin resistance in non-obese, non-insulin-dependent diabetic patients with diabetic nephropathy. |
Q43638278 | Insulin resistance precedes the appearance of albuminuria in non-diabetic subjects: 6 years follow up study |
Q51599898 | Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. |
Q38598332 | Interventions based on microalbuminuria screening and low-protein diet in the treatment of kidney disease of diabetes mellitus |
Q33852450 | Is it possible to predict diabetic kidney disease? |
Q44498867 | Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study |
Q69782467 | Kidney function in newly diagnosed type 2 (non-insulin-dependent) diabetic patients, before and during treatment |
Q61328730 | Long-term effects of amlodipine versus fosinopril on microalbuminuria in elderly hypertensive patients with type 2 diabetes mellitus |
Q72651968 | Long-term glycemic control and the rate of progression of early diabetic kidney disease |
Q41689300 | Markers of diabetic nephropathy |
Q35163137 | Metabolic acidosis-induced insulin resistance and cardiovascular risk |
Q68032081 | Microalbuminuria |
Q36255435 | Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk? |
Q36683530 | Microalbuminuria and coronary heart disease in non-diabetics |
Q35197102 | Microalbuminuria and diabetic cardiovascular disease |
Q44064903 | Microalbuminuria and intima-media thickness of the carotid artery in clinically healthy men. |
Q39762088 | Microalbuminuria as a predictor of clinical diabetic nephropathy |
Q35167321 | Microalbuminuria as predictor of increased mortality in elderly people |
Q41914147 | Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey |
Q70768900 | Microalbuminuria does not predict cardiovascular disease in a normal general practice population |
Q73498928 | Microalbuminuria in Patients with Non-Insulin-dependent Diabetes Mellitus Relates to Nocturnal Systolic Blood Pressure |
Q39404247 | Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area |
Q33786866 | Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications |
Q34381747 | Microalbuminuria in inflammatory bowel disease |
Q36683095 | Microalbuminuria in non-insulin-dependent (type 2) Nigerian diabetics: relation to glycaemic control, blood pressure and retinopathy |
Q36894762 | Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients |
Q33564421 | Microalbuminuria in systemic sclerosis |
Q34825007 | Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy |
Q50960655 | Microalbuminuria is not associated with cardiovascular death in Japanese NIDDM. |
Q45295195 | Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients |
Q40431039 | Microalbuminuria: Prognostic and Therapeutic Implications in Diabetic and Hypertensive Pregnancy |
Q52875754 | Microproteinuria in Type 2 Diabetes Mellitus from Diagnosis |
Q33788444 | Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid? |
Q50920620 | NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. |
Q40846304 | Nephropathy and hypertension in diabetes |
Q36683483 | Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). |
Q41104987 | Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria |
Q43155243 | Predictive value of microalbuminuria in longstanding insulin dependent diabetes |
Q36600524 | Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. |
Q61948450 | Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients |
Q53771713 | Prevalence of microalbuminuria in maturity onset primarily non-insulin-requiring diabetes mellitus: effect of disease duration, glycemic control, and mean systemic blood pressure. |
Q36894434 | Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. |
Q33608889 | Prevalence of microalbuminuria, lipoprotein (a) and coronary artery disease in the lipid clinic |
Q36648858 | Preventing microalbuminuria in patients with type 2 diabetes |
Q40923073 | Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM). |
Q40415958 | Prevention of diabetic renal disease with special reference to microalbuminuria |
Q32135671 | Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria. |
Q44209360 | Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study |
Q72616614 | Prognostic value of urinary albumin excretion rate and other risk factors in elderly diabetic patients and non-diabetic control subjects surviving the first 5 years after assessment |
Q46090183 | Progression of overt nephropathy in non-insulin-dependent diabetes |
Q57740575 | Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study |
Q33892174 | Proteinuria: its clinical importance and role in progressive renal disease. |
Q34070807 | Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus |
Q95811363 | Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity |
Q37048431 | Relationship between diabetic dyslipoproteinaemia and coronary heart disease risk in subjects with non-insulin-dependent diabetes mellitus |
Q46505819 | Relationship of elevated urinary albumin excretion to components of the metabolic syndrome in non-insulin-dependent diabetes mellitus. |
Q50605232 | Relationship of progressively increasing albuminuria to apoprotein(a) and blood pressure in type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetic patients. |
Q72616634 | Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria |
Q40781800 | Renal function changes in middle-aged and elderly Caucasian type 2 (non-insulin-dependent) diabetic patients--a review |
Q41431044 | Renal mortality associated with non-insulin-dependent diabetes mellitus |
Q44070281 | Renoprotective effects of low-dose valsartan in type 2 diabetic patients with diabetic nephropathy |
Q70109628 | Risk of nephropathy in diabetes mellitus: problems of methodology and terminology |
Q54440004 | Screening for Microalbuminuria in Type 2 Diabetic Patients: the Evaluation of a Dipstick Test in General Practice |
Q37124877 | Screening for Microalbuminuria: Which Measurement? |
Q73795277 | Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model |
Q46700898 | Sodium-lithium countertransport is associated with insulin resistance and urinary albumin excretion in young African-Americans |
Q72616733 | Storage temperature and differing methods of sample preparation in the measurement of urinary albumin |
Q72679449 | Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects |
Q41431039 | The Deidesheimer meeting: significance of classical and new risk factors in non-insulin-dependent diabetes mellitus |
Q68234601 | The Prevalence of Hypercholesterolaemia and its Relationship With Albuminuria in Insulin-dependent Diabetic Patients: An Epidemiological Study |
Q70760004 | The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy |
Q77926908 | The changes of lacunar state during a 5-year period in NIDDM |
Q34200394 | The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus |
Q36024390 | The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate |
Q56945006 | The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics |
Q39748109 | The kidney in diabetes: significance of the early abnormalities |
Q39610361 | The long-term care of non-insulin-dependent diabetes |
Q35715065 | The management of diabetic proteinuria. Which antihypertensive agent? |
Q35087669 | The meaning of microalbuminuria in type 1 diabetes: the need for a new paradigm |
Q39578357 | The natural history of non-insulin-dependent diabetes mellitus |
Q72258292 | The relationship of urinary albumin excretion rate to ambulatory blood pressure and erythrocyte sodium-lithium countertransport in NIDDM |
Q72616618 | Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients |
Q70495327 | UK Prospective Diabetes Study (UKPDS). IX: Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy |
Q67834120 | UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance |
Q72616609 | UK Prospective Diabetes Study (UKPDS). X. Urinary albumin excretion over 3 years in diet-treated type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia |
Q38492248 | Update on blood pressure control and renal outcomes in diabetes mellitus |
Q71993556 | Urinary Albumin Excretion in a Population Based Cohort |
Q51585793 | Urinary albumin excretion rate and 24-h ambulatory blood pressure in NIDDM with microalbuminuria: effects of a monounsaturated-enriched diet. |
Q51577626 | Urinary albumin excretion rate is related to insulin resistance in normotensive subjects with impaired glucose tolerance. |
Q73484892 | Use of urine specific gravity to improve screening for albuminuria |
Q73526387 | Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group |
Q44976642 | Vascular risk factors in Japanese non-insulin-dependent diabetic patients with microalbuminuria |
Q68055622 | Vectorcardiographic evaluation of diabetic cardiomyopathy and of its contributing factors |
Q84333398 | [Diabetic nephropathy and cardiovascular risk] |
Search more.